Changes in regional brain activation related to depressive state: A 2-year longitudinal functional MRI study

Depression and Anxiety

Volumn 33, Issue 1, 2016, Pages 35-44

  Opmeer, Esther M ^a   Kortekaas, Rudie ^a   Van Tol, Marie José ^a   Renken, Remco J ^a   Demenescu, Liliana R ^b   Woudstra, Saskia ^c,d,e,f   Ter Horst, Gert J ^a   Van Buchem, Mark A ^c,f   Van Der Wee, Nic J A ^c,f   Veltman, Dick J ^d,e   Aleman, André ^a,g  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

^f LEIDEN UNIVERSITY   (Netherlands)

^g UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

ACC; depression; fMRI; insula; remission

Indexed keywords

CITALOPRAM; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; OXAZEPAM; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; EMOTION; FACIAL EXPRESSION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUSIFORM GYRUS; HUMAN; INFERIOR FRONTAL GYRUS; INSULA; LEFT HEMISPHERE; LONGITUDINAL STUDY; MALE; MIDDLE FRONTAL GYRUS; PARAHIPPOCAMPAL GYRUS; POSTCENTRAL GYRUS; PRIORITY JOURNAL; REMISSION; RIGHT HEMISPHERE; BRAIN; BRAIN MAPPING; CLINICAL TRIAL; MULTICENTER STUDY; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PSYCHOLOGY;

ADULT; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER; EMOTIONS; FACIAL EXPRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NETHERLANDS;

EID: 84954075854     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22425     Document Type: Article

References (53)

1. Gotlib IH, Joormann J,. Cognition and depression: current status and future directions. Annu Rev Clin Psychol 2010; 6: 285-312.
2. Hamilton JP, Etkin A, Furman DJ, et al., Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of baseline activation and neural response data. Am J Psychiatry 2012; 169 (7): 693-703.
3. Phillips ML, Drevets WC, Rauch SL, Lane R,. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 2003; 54 (5): 515-528.
4. Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ,. A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp 2008; 29 (6): 683-695.
5. Delaveau P, Jabourian M, Lemogne C, et al., Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies. J Affect Disord 2011; 130 (1-2): 66-74.
6. Ruhe HG, Booij J, Veltman DJ, et al., Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. J Clin Psychiatry 2012; 73 (4): 451-459.
7. Arce E, Simmons AN, Lovero KL, et al., Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 2008; 196 (4): 661-672.
8. Harmer CJ, Mackay CE, Reid CB, et al., Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006; 59 (9): 816-820.
9. Fu CH, Steiner H, Costafreda SG,. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis 2013; 52: 75-83.
10. Pizzagalli DA., Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011; 36 (1): 183-206.
11. Siegle GJ, Thompson WK, Collier A, et al., Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Arch Gen Psychiatry 2012; 69 (9): 913-924.
12. Penninx BW, Beekman AT, Smit JH, et al., The netherlands study of depression and anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008; 17 (3): 121-140.
13. Robins LN, Wing J, Wittchen HU, et al., The composite international diagnostic interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 1988; 45 (12): 1069-1077.
14. Montgomery SA, Asberg M,. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
15. Zimmerman M, Chelminski I, Posternak M,. A review of studies of the montgomery-asberg depression rating scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol 2004; 19 (1): 1-7.
16. Zimmerman M, Posternak MA, Chelminski I,. Derivation of a definition of remission on the montgomery-asberg depression rating scale corresponding to the definition of remission on the hamilton rating scale for depression. J Psychiatr Res 2004; 38 (6): 577-582.
17. Demenescu LR, Renken R, Kortekaas R, et al., Neural correlates of perception of emotional facial expressions in out-patients with mild-to-moderate depression and anxiety. A multicenter fMRI study. Psychol Med 2011; 41 (11): 2253-2264.
18. Beck AT, Epstein N, Brown G, Steer RA,. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56 (6): 893-897.
19. Penninx BW, Nolen WA, Lamers F, et al., Two-year course of depressive and anxiety disorders: results from the netherlands study of depression and anxiety (NESDA). J Affect Disord 2011; 133 (1-2): 76-85.
20. Spijker J, de Graaf R, Bijl RV, et al., Duration of major depressive episodes in the general population: results from the Netherlands mental health survey and incidence study (NEMESIS). Br J Psychiatry 2002; 181: 208-213.
21. Lyketsos CG, Nestadt G, Cwi J, et al., The life chart interview: a standardized method to describe the course of psychopathology. Int J Methods Psychiatr Res 1994; 4 (3): 143-515.
22. Lundqvist D, Flykt A, Ohmann A,. The Karolinska Directed Emotional Faces (KDEF). Stockholm: Karolinska Institute; 1998.
23. SPSS Inc. SPSS, 16. Chicago, Il, USA.
24. The MathWorks Inc. Matlab, 7.1. Natick, MA, USA.
25. Blasi G, Hariri AR, Alce G, et al., Preferential amygdala reactivity to the negative assessment of neutral faces. Biol Psychiatry 2009; 66 (9): 847-853.
26. Wright P, Liu Y,. Neutral faces activate the amygdala during identity matching. Neuroimage 2006; 29 (2): 628-636.
27. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH,. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003; 19 (3): 1233-1239.
28. Mayberg HS, Liotti M, Brannan SK, et al., Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156 (5): 675-682.
29. Fu CH, Williams SC, Cleare AJ, et al., Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 2004; 61 (9): 877-889.
30. Delaveau P, Jabourian M, Lemogne C, et al., Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies. J Affect Disord 2011; 130 (1-2): 66-74.
31. Kennedy SH, Evans KR, Kruger S, et al., Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001; 158 (6): 899-905.
32. Mayberg HS, Brannan SK, Tekell JL, et al., Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000; 48 (8): 830-843.
33. Craig AD., How do you feel-now? The anterior insula and human awareness. Nat Rev Neurosci 2009; 10 (1): 59-70.
34. Hennenlotter A, Schroeder U, Erhard P, et al., A common neural basis for receptive and expressive communication of pleasant facial affect. Neuroimage 2005; 26 (2): 581-591.
35. Mufson EJ, Mesulam MM, Pandya DN,. Insular interconnections with the amygdala in the rhesus monkey. Neuroscience 1981; 6 (7): 1231-1248.
36. Allman JM, Tetreault NA, Hakeem AY, et al., The von economo neurons in frontoinsular and anterior cingulate cortex in great apes and humans. Brain Struct Funct 2010; 214 (5-6): 495-517.
37. Davidson RJ, Irwin W, Anderle MJ, Kalin NH,. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003; 160 (1): 64-75.
38. Chen CH, Ridler K, Suckling J, et al., Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007; 62 (5): 407-414.
39. Keedwell P, Drapier D, Surguladze S, et al., Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score. J Psychopharmacol 2009; 23 (7): 775-788.
40. Fu CH, Williams SC, Cleare AJ, et al., Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 2008; 64 (6): 505-512.
41. Roy M, Harvey PO, Berlim MT, et al., Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression. J Psychiatry Neurosci 2010; 35 (3): 152-162.
42. Geschwind N, Nicolson NA, Peeters F, et al., Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy. Eur Neuropsychopharmacol 2011; 21 (3): 241-247.
43. Sabatinelli D, Fortune EE, Li Q, et al., Emotional perception: meta-analyses of face and natural scene processing. Neuroimage 2011; 54 (3): 2524-2533.
44. Adolphs R., Recognizing emotion from facial expressions: psychological and neurological mechanisms. Behav Cogn Neurosci Rev 2002; 1 (1): 21-62.
45. Frodl T, Scheuerecker J, Albrecht J, et al., Neuronal correlates of emotional processing in patients with major depression. World J Biol Psychiatry 2009; 10 (3): 202-208.
46. Sheline YI, Barch DM, Donnelly JM, et al., Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001; 50 (9): 651-658.
47. Siegle GJ, Thompson W, Carter CS, et al., Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry 2007; 61 (2): 198-209.
48. Surguladze S, Brammer MJ, Keedwell P, et al., A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry 2005; 57 (3): 201-209.
49. Suslow T, Konrad C, Kugel H, et al., Automatic mood-congruent amygdala responses to masked facial expressions in major depression. Biol Psychiatry 2010; 67 (2): 155-610.
50. Victor TA, Furey ML, Fromm SJ, et al., Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Arch Gen Psychiatry 2010; 67 (11): 1128-1138.
51. Groenewold NA, Opmeer EM, de Jonge P, et al., Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies. Neurosci Biobehav Rev 2013; 37 (2): 152-163.
52. Spijker J, de Graaf R, Bijl RV, et al., Determinants of persistence of major depressive episodes in the general population. Results from the Netherlands mental health survey and incidence study (NEMESIS). J Affect Disord 2004; 81 (3): 231-240.
53. Huskisson EC., Measurement of pain. Lancet 1974; 2 (7889): 1127-1131.